| http://www.w3.org/ns/prov#value | - The provisional nature of the draft guidances is emphasized by the qualifying language throughout that the requirement for almost all the suggested types of evidence can be waived upon an adequate showing of the absence of differences between the biosimilar and the reference biologic drug.
|
